Two Sigma Investments
TLIS

Two Sigma Investments’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Two Sigma Investments’s Portfolio TLIS Stock Details TLIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,187
Closed -$14K – 2919
2022
Q2 		$14K Sell
1,187
-3,735
-76% -$59.1K ﹤0.01% 2425
2022
Q1 		$104K Sell
4,922
-320
-6% -$11.1K ﹤0.01% 2427
2021
Q4 		$315K Buy
+5,242
New +$392K ﹤0.01% 3615

Other funds holding TLIS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments's TLIS Position: Q3 2022 in Review

Two Sigma Investments sold out of Talis Biomedical Corporation Common Stock (TLIS) in Q3 2022, closing a stake of 1,187 shares — an estimated $14K sold.

Two Sigma Investments first reported a position in TLIS in Q4 2021 and held it in 3 quarters. The position peaked at $315K in Q4 2021. 29 funds tracked by Wall St. Rank hold TLIS as of Q3 2022.

  • Two Sigma Investments reported no remaining Talis Biomedical Corporation Common Stock position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Investments sold 1,187 Talis Biomedical Corporation Common Stock shares in Q3 2022, an estimated $14K.
  • Two Sigma Investments first reported a position in Talis Biomedical Corporation Common Stock in Q4 2021 and held it in 3 quarters.
  • Two Sigma Investments's Talis Biomedical Corporation Common Stock position peaked at $315K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Talis Biomedical Corporation Common Stock as of Q3 2022.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.